Srinivas Akkaraju's Net Worth

$299 Million

Who is Srinivas Akkaraju?

Srinivas Akkaraju has an estimated net worth of $299 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, Principia Biopharma Inc., PHARMOS CORP, EYETECH PHARMACEUTICALS INC, CARGO Therapeutics, Inc., Mineralys Therapeutics, Inc., ZS Pharma, Inc., BARRIER THERAPEUTICS INC, HISTOGENICS CORP, INTERCEPT PHARMACEUTICALS, INC., Graphite Bio, Inc., Aclaris Therapeutics, Inc., CHINOOK THERAPEUTICS, INC., Syros Pharmaceuticals, Inc., Jiya Acquisition Corp., Mirna Therapeutics, Inc., aTYR PHARMA INC, MEI Pharma, Inc., Transcept Pharmaceuticals Inc, Durata Therapeutics, Inc., Aravive, Inc., Scholar Rock Holding Corp, SYNAGEVA BIOPHARMA CORP, ICAGEN INC, Spark Therapeutics, Inc., WORLD HEART CORP, and ALIMERA SCIENCES INC.

SEC CIK

Srinivas Akkaraju's CIK is 0001253170

Past Insider Trading and Trends

2014 was Srinivas Akkaraju's most active year for acquiring shares with 26 total transactions. Srinivas Akkaraju's most active month to acquire stocks was the month of April. 2008 was Srinivas Akkaraju's most active year for disposing of shares, totalling 82 transactions. Srinivas Akkaraju's most active month to dispose stocks was the month of June. 2021 saw Srinivas Akkaraju paying a total of $37,935,355.73 for 9,584,999 shares, this is the most they've acquired in one year. In 2004 Srinivas Akkaraju cashed out on 6,325,177 shares for a total of $79,440,025.75, their largest year based on trade value.